Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
Hs 578T
TNBC
Basal B
GSK1838705A
IGF1R
RTK
10379.092
uM
inf
inf
0.8925 0.8925 0.0000 0.0585
-0.0549
2.5811
BT-474
HER2amp
Luminal
Methotrexate
DHFR
Metabolism
5905.085
uM
inf
inf
0.8672 0.8672 0.0000 0.0580
0.2028
0.8847
HCC1187
TNBC
Basal A
FTase Inhibitor I
Ftase
MAPK
10753.154
uM
inf
inf
1.0162 1.0162 0.0000 -0.0376
-5.9291
1.4444
HCC1187
TNBC
Basal A
FTase Inhibitor I
Ftase
MAPK
10518.142
uM
inf
inf
0.9343 0.9343 0.0000 0.0364
-0.0557
1.2869
LY2
HR+
Luminal
Cetuximab
EGFR
ErbB
10264.026
uM
inf
inf
0.9706 0.9706 0.0000 -0.0006
0.1039
1.5047
MDA-MB-361
HER2amp
Luminal
Nutlin 3a
MDM2
MDM2
7508.066
uM
inf
inf
0.8080 0.8080 0.0000 0.1475
0.5518
0.8980
AU565
HER2amp
Luminal
Cisplatin
DNA cross-linker
DNA cross-linker
9146.049
uM
inf
inf
0.5485 0.5485 0.0000 0.3293
0.0796
1.1054
HCC3153
TNBC
Basal A
GW843682X
PLK
PLK
10577.139
uM
inf
inf
1.0500 1.0500 0.0000 -0.0263
-0.5932
0.9234
HCC38
TNBC
Basal B
TCS PIM-1 1
Pim kinase
PIM
10578.135
uM
inf
inf
0.9081 0.9081 0.0000 0.0395
0.0248
1.7650
HCC202
HER2amp
Luminal
Disulfiram
Proteasome
Proteasome
13135.174
uM
inf
inf
-0.5009 -0.5009 0.0000 0.5075
0.5614
0.5256
HCC202
HER2amp
Luminal
PS-1145
IKK
NFKB
7458.065
uM
inf
inf
1.0500 1.0500 0.0000 -0.0275
-0.6310
0.4917
MDA-MB-134-VI
HR+
Luminal
SB-3CT
MMP2/9
MMP
10998.144
uM
inf
inf
0.8777 0.8777 0.0000 0.0210
0.4718
0.8153
HCC70
TNBC
Basal A
Pevonedistat
NAE1
NAE1
10873.148
uM
inf
inf
0.9161 0.9161 0.0000 0.1719
0.0430
1.2150
MDA-MB-361
HER2amp
Luminal
PS-1145
IKK
NFKB
7508.065
uM
inf
inf
1.0103 1.0103 0.0000 0.0104
0.0000
0.7854
MCF12A
NM
Basal B
Nilotinib
ABL
nRTK
10817.145
uM
inf
inf
0.9556 0.9556 0.0000 0.0393
0.0596
1.5564
HCC38
TNBC
Basal B
Dactolisib
PI3K
PI3K
11850.155
uM
inf
inf
0.5069 0.5069 0.0000 0.3134
0.5180
2.1810
HCC202
HER2amp
Luminal
GSK1838705A
IGF1R
RTK
7458.091
uM
inf
inf
1.0005 1.0005 0.0000 0.1959
0.0969
0.5499
MDA-MB-415
HR+
Luminal
Lapatinib
EGFR/HER2
ErbB
7511.098
uM
inf
inf
0.9618 0.9618 0.0000 0.0309
0.2078
1.2032
MDA-MB-415
HR+
Luminal
AG1024
IGF1R
RTK
7512.066
uM
inf
inf
0.9738 0.9738 0.0000 -0.0064
-0.0661
0.8629
Hs 578T
TNBC
Basal B
PS-1145
IKK
NFKB
7475.065
uM
inf
inf
1.0453 1.0453 0.0000 -0.0447
-24.5864
2.6262
HCC1143
TNBC
Basal A
(Z)-4-Hydroxytamoxifen
ESR1
7809.016
uM
inf
inf
0.3854 0.3854 0.0000 0.1556
0.5101
1.6622
MDA-MB-175-VII
HR+
Luminal
Celecoxib
COX2
COX
10642.136
uM
inf
inf
0.5259 0.5259 0.0000 0.1780
0.0542
0.5193
HCC1954
HER2amp
Basal A
PS-1145
IKK
NFKB
7457.065
uM
inf
inf
0.8494 0.8494 0.0000 0.0471
0.0632
1.5870
MDA-MB-175-VII
HR+
Luminal
Methotrexate
DHFR
Metabolism
7499.084
uM
inf
inf
0.8028 0.8028 0.0000 0.0973
-0.0768
0.7991
LY2
HR+
Luminal
L-779450
BRAF
MAPK
12319.166
uM
inf
inf
0.6126 0.6126 0.0000 0.2273
0.0745
1.3789